Christopher A. Toth - 06 Mar 2024 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role: EVP,Group Pres, Kidney Care
Signature: /s/ Ellen K. Bradford, as attorney in-fact for Christopher A. Toth
Issuer symbol: BAX
Transactions as of: 06 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Mar 2024, 16:12:00 UTC
Previous filing: 05 Jun 2023
Next filing: 05 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BAX	Common Stock, $1 par value	Award	$0	+119,076	+110%	$0.000000	227,761	06 Mar 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2	Total includes the automatic reinvestment of dividends.

Content

For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

Total includes the automatic reinvestment of dividends.